PDGFRB and neoplasm: Han et al. stated that circulating tumor DNA could be used to measure the tumor load and detect EGFR, PIK3CA, BRAF, KRAS, HER2, ALK, PDGFR, and KIT mutations in multiple cancer types, such as lung, pancreas, breast, prostate, and colorectal cancer [44].